Dr. Moonkyoung Um is a patent agent in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s patents and innovations practice. She focuses on patent prosecution, due diligence matters, and patent portfolio management for clients in the fields of life sciences, biotechnologies, small molecules, pharmaceuticals, diagnostics, health information technologies, and medical devices.
Moonkyoung obtained her Ph.D. degree from the Department of Biological Sciences at Columbia University and received her postdoctoral training at the Whitehead Institute for Biomedical Research under the guidance of Dr. Harvey F. Lodish. After her postdoctoral training, she continued her scientific career at the Boston Biomedical Research Institute as a principal investigator and at Boston Children’s Hospital as a research scientist. Through her decades-long career in science, Moonkyoung acquired broad-based experience in the fields of life sciences, including biochemistry, cell biology, molecular biology, mouse genetics, yeast genetics, cancer biology, immunology, neurobiology, metabolic disorders, cardiovascular diseases, and neurological diseases, as well as chemistry and pharmaceutical sciences.
Dr. Moonkyoung Um is a patent agent in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s patents and innovations practice. She focuses on patent prosecution, due diligence matters, and patent portfolio management for clients in the fields of life sciences, biotechnologies, small molecules, pharmaceuticals, diagnostics, health information technologies, and medical devices.
Moonkyoung obtained her Ph.D. degree from the Department of Biological Sciences at Columbia University and received her postdoctoral training at the Whitehead Institute for Biomedical Research under the guidance of Dr. Harvey F. Lodish. After her postdoctoral training, she continued her scientific career at the Boston Biomedical Research Institute as a principal investigator and at Boston Children’s Hospital as a research scientist. Through her decades-long career in science, Moonkyoung acquired broad-based experience in the fields of life sciences, including biochemistry, cell biology, molecular biology, mouse genetics, yeast genetics, cancer biology, immunology, neurobiology, metabolic disorders, cardiovascular diseases, and neurological diseases, as well as chemistry and pharmaceutical sciences.
- Postdoctoral Associate/Fellow, Whitehead Institute for Biomedical Research, 2007Recipient, American Heart Association Postdoctoral Fellowship, 2002-2004
- Ph.D., Department of Biological Sciences, Columbia University, 2000Recipient, James Howard McGregor Prize
- M.S., Biochemistry, College of Pharmacy, Seoul National University, 1991
- B.S., Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, 1989Recipient, KeumKang Foundation Scholarship
- U.S. Patent and Trademark Office
- Postdoctoral Associate/Fellow, Whitehead Institute for Biomedical Research, 2007Recipient, American Heart Association Postdoctoral Fellowship, 2002-2004
- Ph.D., Department of Biological Sciences, Columbia University, 2000Recipient, James Howard McGregor Prize
- M.S., Biochemistry, College of Pharmacy, Seoul National University, 1991
- B.S., Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, 1989Recipient, KeumKang Foundation Scholarship
- U.S. Patent and Trademark Office
Select Publications
- Co-author with K. Zarringhalam, M. Ka, Y.-H. Kook, J. I. Terranova, Y. Suh, and O. D. King, “An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease,” 229(1) Behavioural Brain Research 216-225, 2012
- Co-author with Y.-H. Kook and M. Ka, “Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP(+)) model of Parkinson’s disease,” 411(2) Biochemical and Biophysical Research Communications 370-374, 2011
- Co-author with M. T. N. Le, H. Xie, B. Zhou, P. H. Chia, P. Rizk, G. Udolph, H. Yang, B. Lim, and H. F. Lodish, “MicroRNA-125b Promotes Neuronal Differentiation in Human Cells by Repressing Multiple Targets,” 29(19) Molecular and Cellular Biology 5290–5305, 2009
- Co-author with A. W. Gross and H.F. Lodish, “A “classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells,” 19(3) Cellular Signalling 634-645, 2007
- Co-author with H. F. Lodish, “Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways,” 281(9) Journal of Biological Chemistry 5648-5656, 2006
- Co-author with J. Yamauchi, S. Kato, and J. L. Manley, “Heterozygous disruption of the TATA-binding protein gene in DT40 cells causes reduced cdc25B phosphatase expression and delayed mitosis,” 21(7) Molecular and Cellular Biology 2435-2448, 2001
- Co-author with J. L. Manley, “The Drosophila TATA binding protein contains a strong but masked activation domain,” 9(3) Gene Expression 123-132, 2000
- Co-author with C. Li and J. L. Manley, “The transcriptional repressor even-skipped interacts directly with TATA-binding protein,” 15(9) Molecular and Cellular Biology 5007-5016, 1995
Select Publications
- Co-author with K. Zarringhalam, M. Ka, Y.-H. Kook, J. I. Terranova, Y. Suh, and O. D. King, “An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease,” 229(1) Behavioural Brain Research 216-225, 2012
- Co-author with Y.-H. Kook and M. Ka, “Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP(+)) model of Parkinson’s disease,” 411(2) Biochemical and Biophysical Research Communications 370-374, 2011
- Co-author with M. T. N. Le, H. Xie, B. Zhou, P. H. Chia, P. Rizk, G. Udolph, H. Yang, B. Lim, and H. F. Lodish, “MicroRNA-125b Promotes Neuronal Differentiation in Human Cells by Repressing Multiple Targets,” 29(19) Molecular and Cellular Biology 5290–5305, 2009
- Co-author with A. W. Gross and H.F. Lodish, “A “classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells,” 19(3) Cellular Signalling 634-645, 2007
- Co-author with H. F. Lodish, “Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways,” 281(9) Journal of Biological Chemistry 5648-5656, 2006
- Co-author with J. Yamauchi, S. Kato, and J. L. Manley, “Heterozygous disruption of the TATA-binding protein gene in DT40 cells causes reduced cdc25B phosphatase expression and delayed mitosis,” 21(7) Molecular and Cellular Biology 2435-2448, 2001
- Co-author with J. L. Manley, “The Drosophila TATA binding protein contains a strong but masked activation domain,” 9(3) Gene Expression 123-132, 2000
- Co-author with C. Li and J. L. Manley, “The transcriptional repressor even-skipped interacts directly with TATA-binding protein,” 15(9) Molecular and Cellular Biology 5007-5016, 1995
- Privacy Policy
- Terms of Use
- Accessibility